Skip to main content
Journal of Patient-Reported Outcomes

Table 4 Correlations between FACT-GOG-Ntx, FACT-GOG-Ntx-4, and CHRIs-Global by rater over time

From: Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

 

Time 1

(Baseline)

Time 2

(D8, Cycle 2)

Time 3

(D8, Cycle 5)

FACT-Ntx and CHRIs-Global

   

 Youth

0.43

0.41

0.45

 Parent-Proxy

0.42

0.44

0.48

FACT-Ntx-4 and CHRIs-Global

   

 Youth

0.21

0.29

0.34

 Parent-Proxy

0.25

0.33

0.37

  1. Higher FACT-GOG-Ntx, FACT-GOG-Ntx-4, and CHRIs-Global scores indicate less symptoms/better functioning, respectively. Youth report is for patients aged 11–21.9 years; parent-proxy report is for youth aged 5–17.9 years.
Back to article page